Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

The Blood Microbiome Predicts Acute Graft-Versus-Host Disease after Stem Cell Transplantation

Lily Blair, PhD, Jonathan U. Peled, MD, Paul A Giardina, John B. Slingerland, BSc, Ann E. Slingerland, BSc, Desiree Hollemon, MPH, MSN, Carine Ho, Sivan Bercovici, Asim Ahmed, David K Hong, MD, Sergio A. Giralt, MD, Ying Taur, MD MPH, Marcel R.M. van den Brink, MD PhD, Kate A Markey, PhDMBBS,FRACP

Blood (2019) 134 (Supplement_1): 4513.

https://doi.org/10.1182/blood-2019-129272

Published: 2019

Journal Articles

Comparison of Procoagulant and Proinflammatory Effects of Nuclear, Mitochondrial, and Bacterial DNA

Vinai C. Bhagirath, MD, Dhruva J. Dwivedi, PhD, Patricia C. Liaw, PhD

Blood (2014) 124 (21): 2815.

https://doi.org/10.1182/blood.V124.21.2815.2815

Published: 2014

Journal Articles

Agonist for Toll-Like Receptor (TLR) 9 Amplifies as Well as Inhibits the Differentiation of FVIII-Specific Memory B Cells into Antibody-Producing Plasma Cells in Vitro and in Vivo.

Peter Allacher, Christina Hausl, PhD, Aniko Ginta Pordes, Rafi Uddin Ahmad, PhD, Hartmut J Ehrlich, MD, Hans Peter Schwarz, MD, Birgit M Reipert, PhD

Blood (2008) 112 (11): 3382.

https://doi.org/10.1182/blood.V112.11.3382.3382

Published: 2008

Journal Articles

Endothelial Cell-Derived Microparticules (EMPs) Can Induce In Vitro Maturation of Both Plasmocytoid and Myeloid Dendritic Cells.

Francine Garnache-Ottou, PhD, Fanny Angelot, Sabeha Biichle, Joel PLumas, PhD, Francoise Dignat George, PhD, Philippe Saas, PhD, Pierre Tiberghien, MD PhD, Estelle Seilles, PhD

Blood (2006) 108 (11): 1273.

https://doi.org/10.1182/blood.V108.11.1273.1273

Published: 2006

Journal Articles

In Vivo CpG Administration Accelerates Graft-Versus-Host Disease (GVHD) Lethality by Toll-Like Receptor 9 (TLR9) Ligation of Host Antigen-Presenting Cells (APCs) and Promotes Allogeneic Bone Marrow (BM) Rejection by TLR9 Ligation of Donor APCs.

Bruce R. Blazar, Angela Panoskaltsis-Mortari, Arthur M. Krieg, Hiroaki Hemmi, Shizuo Akira, Jonathan Serody, William J. Murphy, Patricia A. Taylor

Blood (2006) 108 (11): 446.

https://doi.org/10.1182/blood.V108.11.446.446

Published: 2006

Journal Articles

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Manuel Schmidt, Javier de Cristobal, Astrid Sander, Bernadette Brzezicha, Sven A. König Merediz, Burghardt Wittig

Blood (2006) 108 (11): 1727.

https://doi.org/10.1182/blood.V108.11.1727.1727

Published: 2006

Journal Articles

Potent Phosphorodiester-Based DNA Immunomodulators (dSLIM) Exhibit Enhanced Safety Compared to Phosphorothioate-Based Oligonucleotides.

Manuel Schmidt, Javier de Christobal, Nicole Hagner, Astrid Sander, Alberto Marco, Sven A. Koenig-Merediz, Burghardt Wittig

Blood (2005) 106 (11): 3915.

https://doi.org/10.1182/blood.V106.11.3915.3915

Published: 2005

Journal Articles

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Manuel Schmidt, Javier de Cristobal, Astrid Sander, Bernadette Brzezicha, Sven A. Koenig-Merediz, Burghardt Wittig

Blood (2005) 106 (11): 5527.

https://doi.org/10.1182/blood.V106.11.5527.5527

Published: 2005

Journal Articles

Toll-Like Receptor Triggering Modulates Factor VIII-Specific Immune Memory in Murine Hemophilia A with Factor VIII Inhibitors.

Peter Allacher, Christina Hausl, PhD, Rafi U. Ahmad, PhD, Hans Peter Schwarz, MD, Peter L. Turecek, PhD, Birgit M. Reipert, PhD

Blood (2005) 106 (11): 214.

https://doi.org/10.1182/blood.V106.11.214.214

Published: 2005

Journal Articles

Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns

Dominique De Wit, Véronique Olislagers, Stanislas Goriely, Françoise Vermeulen, Hermann Wagner, Michel Goldman, Fabienne Willems

Blood (2004) 103 (3): 1030–1032.

https://doi.org/10.1182/blood-2003-04-1216

Published: 2004

Journal Articles

Immunostimulatory Oligodeoxynucleotides Containing CpG Motifs Enhance the Efficacy of Monoclonal Antibody Therapy of Lymphoma

James E. Wooldridge, Zuhair Ballas, Arthur M. Krieg, George J. Weiner

Blood (1997) 89 (8): 2994–2998.

https://doi.org/10.1182/blood.V89.8.2994

Published: 1997

NARROW

The Blood Microbiome Predicts Acute Graft-Versus-Host Disease after Stem Cell Transplantation

Comparison of Procoagulant and Proinflammatory Effects of Nuclear, Mitochondrial, and Bacterial DNA

Agonist for Toll-Like Receptor (TLR) 9 Amplifies as Well as Inhibits the Differentiation of FVIII-Specific Memory B Cells into Antibody-Producing Plasma Cells in Vitro and in Vivo.

Endothelial Cell-Derived Microparticules (EMPs) Can Induce In Vitro Maturation of Both Plasmocytoid and Myeloid Dendritic Cells.

In Vivo CpG Administration Accelerates Graft-Versus-Host Disease (GVHD) Lethality by Toll-Like Receptor 9 (TLR9) Ligation of Host Antigen-Presenting Cells (APCs) and Promotes Allogeneic Bone Marrow (BM) Rejection by TLR9 Ligation of Donor APCs.

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Potent Phosphorodiester-Based DNA Immunomodulators (dSLIM) Exhibit Enhanced Safety Compared to Phosphorothioate-Based Oligonucleotides.

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Toll-Like Receptor Triggering Modulates Factor VIII-Specific Immune Memory in Murine Hemophilia A with Factor VIII Inhibitors.

Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns

Immunostimulatory Oligodeoxynucleotides Containing CpG Motifs Enhance the Efficacy of Monoclonal Antibody Therapy of Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only